Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 13 , ISSUE 4 ( October-December, 2024 ) > List of Articles

CASE REPORT

An Unusual Case of Thoracic Empyema due to Blastocystis hominis

Rania Imaniar, Ika P Sari, Diah Handayani, Aditya Wirawan

Keywords : Blastocystis, Case report, Empyema, Pleural effusion

Citation Information : Imaniar R, Sari IP, Handayani D, Wirawan A. An Unusual Case of Thoracic Empyema due to Blastocystis hominis. Indian J Respir Care 2024; 13 (4):256-258.

DOI: 10.5005/jp-journals-11010-1143

License: CC BY-NC 4.0

Published Online: 17-02-2025

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Introduction: Blastocystis hominis is a single-celled organism that is usually found in the intestinal tract. Clinical manifestations of B. hominis infection in humans are nonspecific and include diarrhea, abdominal pain, cramps or discomfort, and nausea. Case description: A 47-year-old male came with a chief complaint of worsened shortness of breath for 2 weeks before being admitted to the hospital. Chest ultrasound showed a large right pleural effusion. We performed thoracocentesis and inserted a chest tube to drain the pus. Lugol staining of the pleural fluid showed the presence of B. hominis. The patient was treated with metronidazole and trimethoprim/sulfamethoxazole (TMP/SMX). Discussion: B. hominis has an equivocal role among intestinal parasites due to a lack of knowledge regarding its biology and evidence of its pathogenicity. Based on this case, the treatment that we provided produced a good response for the patient, and B. hominis as the cause of the disease can be considered. Conclusion: Despite it being thought to only infect the intestinal tract, in this case, we found that B. hominis can also be the cause of thoracic empyema. Treatment with metronidazole and TMP/SMX in the patient resulted in the resolution of the disease.


PDF Share
  1. Stenzel DJ, Boreham PF. Blastocystis hominis revisited. Clin Microbiol Rev 1996;9(4):563–584. DOI: 10.1128/CMR.9.4.563
  2. Stensvold CR, Nielsen HV, Mølbak K, et al. Pursuing the clinical significance of Blastocystis—diagnostic limitations. Trends Parasitol 2009;25(1):23–29. DOI: 10.1016/j.pt.2008.09.010
  3. Roberts T, Stark D, Harkness J, et al. Update on the pathogenic potential and treatment options for Blastocystis sp. Gut Pathog 2014;6:17. DOI: 10.1186/1757-4749-6-17
  4. Kasprzak J, Szaładzińska B, Smoguła M, et al. Intestinal parasites stool samples and perianal swabs examined by The Voivodeship Sanitary-Epidemiological Station in Bydgoszcz between 2000–2014in. Przegl Epidemiol 2017;71(1):45–54.
  5. El Safadi D, Gaayeb L, Meloni D, et al. Children of Senegal river basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infect Dis 2014;14:164. DOI: 10.1186/1471-2334-14-164
  6. Li XX, Chen JX, Wang LX, et al. Intestinal parasite co-infection among pulmonary tuberculosis cases without human immunodeficiency virus infection in a rural county in China. Am J Trop Med Hyg 2014;90(1):106–113. DOI: 10.4269/ajtmh.13-0426
  7. Gong B, Liu X, Wu Y, et al. Prevalence and subtype distribution of Blastocystis in ethnic minority groups on both sides of the China-Myanmar border, and assessment of risk factors. Parasite 2019;26:46. DOI: 10.1051/parasite/2019046
  8. Kain KC, Noble MA, Freeman HJ, et al. Epidemiology and clinical features associated with Blastocystis hominis infection. Diagn Microbiol Infect Dis 1987;8(4):235–244. DOI: 10.1016/0732-8893(87)90055-1
  9. Rudzińska M, Sikorska K. Epidemiology of Blastocystis infection: a review of data from Poland in relation to other reports. Pathogens 2023;12:1050. DOI: 10.3390/pathogens12081050
  10. Moghaddam DD, Ghadirian E, Azami M. Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole. Parasitol Res 2005;96(4):273–275. DOI: 10.1007/s00436-005-1363-1
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.